Ocella is the generic form of Yasmin birth control, produced by Bayer Pharmaceuticals.  Yasmin and Ocella were approved by the FDA as oral contrceptives and to treat symptoms of Premenstrual dysphoric disorder (PMDD).  Neither drug was approved to treat acne or PreMenstrual Syndrome (PMS).

Ocella has been marketed throughout the country in a misleading way, and women have suffered needlessly, claims the potential class action Ocella lawsuit.  Television commercials feature women apparently suffering from PMS symptoms such as bloating and breakouts, neither of which are symptoms of PMDD.  The ads show happy women with very clear skin, supposedly because they had taken Ocella, and this is misleading.

In addition to making misleading claims for the drug, the Ocella lawsuit states that dangerous side effects are downplayed or not even mentioned, giving a false impression of the drug.  Ocella side effects such as blood clots and gall bladder disease are not sufficiently addressed in the TV commercials.

Blood clots are serious health risks, and can lead to stroke, heart attack, and even death.  Gall bladder disease and gallstones may lead to gall bladder removal surgery.  Participants in the Ocella lawsuit seek compensation for their pain and suffering, as well as medical expenses.